215 related articles for article (PubMed ID: 30861618)
1. Identification of compounds that inhibit the binding of Keap1a/Keap1b Kelch DGR domain with Nrf2 ETGE/DLG motifs in zebrafish.
Raghunath A; Nagarajan R; Sundarraj K; Palanisamy K; Perumal E
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):259-270. PubMed ID: 30861618
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of keap1a- and keap1b-knockout zebrafish.
Nguyen VT; Bian L; Tamaoki J; Otsubo S; Muratani M; Kawahara A; Kobayashi M
Redox Biol; 2020 Sep; 36():101667. PubMed ID: 32828016
[TBL] [Abstract][Full Text] [Related]
3. Genetic hyperactivation of Nrf2 causes larval lethality in Keap1a and Keap1b-double-knockout zebrafish.
Bian L; Nguyen VT; Tamaoki J; Endo Y; Dong G; Sato A; Kobayashi M
Redox Biol; 2023 Jun; 62():102673. PubMed ID: 36934645
[TBL] [Abstract][Full Text] [Related]
4. Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish.
Li L; Kobayashi M; Kaneko H; Nakajima-Takagi Y; Nakayama Y; Yamamoto M
J Biol Chem; 2008 Feb; 283(6):3248-3255. PubMed ID: 18057000
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
6. The chromatin-remodeling enzyme Smarca5 regulates erythrocyte aggregation via Keap1-Nrf2 signaling.
Ding Y; Li Y; Zhao Z; Cliff Zhang Q; Liu F
Elife; 2021 Oct; 10():. PubMed ID: 34698638
[TBL] [Abstract][Full Text] [Related]
7. Shinorine ameliorates chromium induced toxicity in zebrafish hepatocytes through the facultative activation of Nrf2-Keap1-ARE pathway.
Shaw P; Sen A; Mondal P; Dey Bhowmik A; Rath J; Chattopadhyay A
Aquat Toxicol; 2020 Nov; 228():105622. PubMed ID: 32947073
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
[TBL] [Abstract][Full Text] [Related]
9. Identification of Nrf2/Keap1 pathway and its transcriptional regulation of antioxidant genes after exposure to microcystins in freshwater mussel Cristaria plicata.
Wu J; Liu W; Hou S; Wang Y; Fang H; Luo S; Yang L; Wen C
Dev Comp Immunol; 2023 Apr; 141():104629. PubMed ID: 36587710
[TBL] [Abstract][Full Text] [Related]
10. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system.
Kobayashi M; Itoh K; Suzuki T; Osanai H; Nishikawa K; Katoh Y; Takagi Y; Yamamoto M
Genes Cells; 2002 Aug; 7(8):807-20. PubMed ID: 12167159
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri.
Wang H; Pan L; Xu R; Si L; Zhang X
Fish Shellfish Immunol; 2019 Sep; 92():489-499. PubMed ID: 31220575
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
Jiang ZY; Lu MC; Xu LL; Yang TT; Xi MY; Xu XL; Guo XK; Zhang XJ; You QD; Sun HP
J Med Chem; 2014 Mar; 57(6):2736-45. PubMed ID: 24512214
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism.
Horie Y; Suzuki T; Inoue J; Iso T; Wells G; Moore TW; Mizushima T; Dinkova-Kostova AT; Kasai T; Kamei T; Koshiba S; Yamamoto M
Commun Biol; 2021 May; 4(1):576. PubMed ID: 33990683
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside CK targeting KEAP1-DGR/Kelch domain disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage.
Cheng C; Zhang J; Liu K; Xu Y; Shen F; Han Y; Hou Y; Zhang T; Bai G
Phytomedicine; 2023 Oct; 119():154992. PubMed ID: 37499433
[TBL] [Abstract][Full Text] [Related]
16. Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases.
Pallesen JS; Tran KT; Bach A
J Med Chem; 2018 Sep; 61(18):8088-8103. PubMed ID: 29750408
[TBL] [Abstract][Full Text] [Related]
17. Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification.
Wang Y; Xiao CY; Lin HQ; Hu JS; Ip TM; Chi-Cheong Wan D
Redox Biol; 2020 Jul; 34():101573. PubMed ID: 32422542
[TBL] [Abstract][Full Text] [Related]
18. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
[TBL] [Abstract][Full Text] [Related]
19. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
Bello M; Morales-González JA
Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
[TBL] [Abstract][Full Text] [Related]
20. Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway.
Zhao X; Gong L; Wang C; Liu M; Hu N; Dai X; Peng C; Li Y
J Ethnopharmacol; 2021 Mar; 268():113569. PubMed ID: 33186701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
